Molecular & Cellular Oncology
ISSN: (Print) 2372-3556 (Online) Journal homepage: https://www.tandfonline.com/loi/kmco20
TRAMM, a new player in CENP-E biology
Miroslav P. Milev & Michael Sacher
To cite this article: Miroslav P. Milev & Michael Sacher (2016) TRAMM, a new player in CENP-E
biology, Molecular & Cellular Oncology, 3:1, e1057314, DOI: 10.1080/23723556.2015.1057314
To link to this article: https://doi.org/10.1080/23723556.2015.1057314
Accepted author version posted online: 10
Jun 2015.
Published online: 01 Feb 2016.
Submit your article to this journal
Article views: 244
View related articles
View Crossmark data
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=kmco20
MOLECULAR & CELLULAR ONCOLOGY
2016, VOL. 3, NO. 1, e1057314 (2 pages)
http://dx.doi.org/10.1080/23723556.2015.1057314
COMMENTARY
TRAMM, a new player in CENP-E biology
Miroslav P. Mileva and Michael Sachera,b
a
Concordia University, Department of Biology, Montreal, Quebec, Canada; bMcGill University, Department of Anatomy and Cell Biology, Montreal,
Quebec, Canada
ABSTRACT
ARTICLE HISTORY
Mitosis is a highly orchestrated process with morphologically defined stages and is subject to checkpoints
that ensure the proper distribution of chromosomes. Centromere-associated protein E (CENP-E), a protein
expressed during mitosis, is a potential target of cancer therapeutics. Our laboratory has recently
implicated a protein called TRAMM (trafficking of membranes and mitosis) in the recruitment of CENP-E to
kinetochores.
Received 22 May 2015
Revised 26 May 2015
Accepted 26 May 2015
Cancer is defined as uncontrolled cell division, often resulting
in aneuploid cells. The ability to selectively stop such division
has been the subject of cancer research for decades. Intuitively,
an ideal therapeutic target would be a protein that is expressed
only during the mitotic phase of the cell cycle. Inhibition of the
function of such a target could, in theory, prevent cell division.
By extension, identifying the full complement of proteins that
interact with such a target, and how these other proteins regulate the function of the target, is a necessary requirement for
the eventual development of therapeutics.
The mitotic kinesin centromere-associated protein E (CENP-E)
integrates several steps within mitosis.1 As a kinesin motor protein,
CENP-E is involved in chromosome congression prior to metaphase by aiding the establishment and maintenance of connections between mitotic chromosomes and spindle microtubules,
and by physically moving the chromosomes to the metaphase
plate. This motor function resides within the amino-terminal
region of the protein. In addition, CENP-E has been reported to
bind to a number of different proteins that mediate the spindle
assembly checkpoint (SAC), a mechanism that ensures proper
chromosome alignment prior to the onset of anaphase. Inhibition
of CENP-E activity by either specific antibodies or RNA interference results in arrest of cell division and eventual death of the cell.
Since CENP-E plays such a critical function during mitosis and is
predominantly expressed during mitosis2 it has become the focus
of cancer therapeutics, with several inhibitors having been
designed and undergoing clinical trials.3
Following chromosome condensation during prophase, a
large protein structure called the kinetochore assembles on the
centromeric region of the DNA. The kinetochore is one of the
most complex protein assemblies known, with over 100 distinct polypeptides associating with it either stably or transiently.4,5 How each of these proteins, including CENP-E,
is recruited to the kinetochore has been the subject of
intense research. Inhibition of several proteins, as well as postCONTACT Michael Sacher
© 2016 Taylor & Francis Group, LLC
michael.sacher@concordia.ca
KEYWORDS
CENP-E; chromosome
congression; mitosis; TRAPP;
TRAMM
translational modification of CENP-E itself, has been reported
to affect recruitment of CENP-E to varying degrees. However,
our new study suggests that a previously unknown player in
mitosis called TRAMM (trafficking of membranes and mitosis;
formerly known as both TTC-15 and TrappC12) affects
CENP-E recruitment to an even greater extent.6
The revelation that TRAMM functions in mitosis was unexpected. This protein was originally identified as a member of a
large complex involved in membrane trafficking called TRAPP
(transport protein particle).7 Indeed, as the twelfth known subunit of this complex, the protein was originally called
TrappC12. Inhibition of TRAMM, but not of any other TRAPP
subunit, in HeLa cells by RNA interference resulted in a sharp
increase in the mitotic index. Analysis of the resulting phenotype revealed a defect in chromosome congression resulting in
activation of the SAC.
Biochemical fractionation of cells demonstrated that small
amounts of TRAMM fractionated with a nuclear marker. A fraction of this protein associated with mitotic chromosomes and
was loosely localized to the kinetochore. The kinetochore localization, combined with the chromosome congression defect, suggested that kinetochore structure may be affected. Indeed, using
fluorescence intensity measurements, a number of kinetochore
proteins were found to have a reduced presence at the kinetochores of aligned chromosomes in TRAMM-deleted cells. These
included proteins that were more distally associated with the
centromere but not proteins proposed to be in the inner kinetochore layer.8 The most profoundly affected protein was CENP-E,
whose level at kinetochores was merely 6% of that in control
cells. This was notable since the phenotype of a TRAMM knockdown resembled that of CENP-E knockdown. A subsequent
recruitment experiment revealed that TRAMM is required for
the recruitment of CENP-E to kinetochores.
Mitotic phosphorylation of TRAMM was documented to
occur as the cells entered mitosis and was complete at the onset
e1057314-2
M. P. MILEV AND M. SACHER
pertaining to the role of CENP-E as a therapeutic target. How
exactly does TRAMM recruit CENP-E? What role does phosphorylation of TRAMM play in this recruitment? What other
proteins interact with TRAMM? Most importantly, can any of
these interactions ultimately be exploited by small molecules as a
potential therapeutic? Future studies on this moonlighting protein will begin to reveal answers to these intriguing questions.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Figure 1. Localization of TRAMM and CENP-E overlaps during early mitosis. During
interphase, TRAMM (trafficking of membranes and mitosis) is a component of the
TRAPP (transport protein particle) membrane trafficking complex and localizes to
Golgi membranes whereas expression of centromere-associated protein E (CENP-E)
is suppressed. Mitotically phosphorylated TRAMM, detected from entry into mitosis
until anaphase, associates with kinetochores and facilitates the recruitment of
CENP-E to these structures. At the onset of anaphase, TRAMM is rapidly dephosphorylated and relocalizes to the emerging Golgi membranes. In contrast, CENP-E
localizes to the midzone during anaphase and then to the midbody during cytokinesis. The solid black lines indicate TRAMM and the dashed red lines indicate
CENP-E. C and – indicate localization or no localization, respectively, and are not
intended to be interpreted quantitatively. Pr: prophase; PrM: prometaphase; M:
metaphase; Ana: anaphase; T: telophase; C: cytokinesis.
of anaphase. This temporal phosphorylation correlated with the
localization patterns of TRAMM and CENP-E; maximal colocalization was detected during mitotic phosphorylation of
TRAMM whereas distinct localization of the 2 proteins was
apparent from anaphase onwards. Specifically, after anaphase
TRAMM relocalized to the Golgi complex, presumably in preparation for the resumption of membrane trafficking, whereas
CENP-E localized to the midzone and ultimately the midbody.
If TRAMM is part of the TRAPP complex during interphase, how is it released from this complex during mitosis to
associate with the kinetochore? Size exclusion chromatography
revealed that the mitotic form of TRAMM was no longer associated with the TRAPP complex and fractionated at a smaller
molecular size. This form of the protein had a slower mobility
on SDS-polyacrylamide gels, suggesting that it is mitotically
phosphorylated. Thus, it is plausible that mitotic phosphorylation of TRAMM releases it from the TRAPP complex.
Phosphorylation of TRAMM is likely required for more
than just release of the protein from the TRAPP complex. Five
potential sites of phosphorylation on the TRAMM polypeptide
were investigated and a phosphomimetic mutant, in which all 5
of these sites were changed to aspartic acid, was shown to
recruit CENP-E more efficiently than the non-phosphorylatable (alanine) mutant. Interestingly, mutation of one of these
residues, the invariant Ser184, has been reported in breast cancer cells (http://www.cbioportal.org).
Other membrane trafficking proteins have been reported to
have mitotic functions.9 However, TRAMM appears to be unique
in that it cycles between two large complexes to perform its two
functions (Fig. 1). Overall, this study identified a new factor
important for CENP-E function, raising interesting questions
Acknowledgments
Funding for the author’s laboratory is provided by the Canadian Institutes
of Health Research, the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation and Concordia University. The laboratory is a member of the Groupe de Recherche Axe sur la
Structure des Proteines (GRASP) network. M.P.M. is a recipient of a
GRASP postdoctoral fellowship.
References
1. Yao X, Abrieu A, Zheng Y, Sullivan KF, Cleveland DW. CENP-E forms
a link between attachment of spindle microtubules to kinetochores and
the mitotic checkpoint. Nat Cell Biol 2000; 2:484–491;
PMID:10934468; http://dx.doi.org/10.1038/35019518
2. Yen TJ, Li G, Schaar BT, Szilak I, Cleveland DW. CENP-E is a
putative kinetochore motor that accumulates just before mitosis.
Nature 1992; 359:536–9; PMID:1406971; http://dx.doi.org/10.1038/
359536a0
3. Lock RB, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Maris
JM, Wozniak AW, Gorlick R, Kolb EA, Houghton PJ, Smith MA. Initial
testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program. Pediatr Blood Cancer 2012; 58:916–23; PMID:
21584937; http://dx.doi.org/10.1002/pbc.23176
4. Cheeseman IM. The Kinetochore. Cold Spring Harb Perspect Biol
2014; 6:1–18; PMID:24984773; http://dx.doi.org/10.1101/cshperspect.
a015826
5. Ohta S, Bukowski-Wills JC, Sanchez-Pulido L, Alves FL, Wood L, Chen
ZA, Platani M, Fischer L, Hudson DF, Ponting CP, et al. The protein
composition of mitotic chromosomes determined using multiclassifier
combinatorial proteomics. Cell 2010; 142:810–21; PMID:20813266;
http://dx.doi.org/10.1016/j.cell.2010.07.047
6. Milev MP, Hasaj B, Saint-Dic D, Snounou S, Zhao Q, Sacher M.
TRAMM/TrappC12 plays a role in chromosome congression, kinetochore stability, and CENP-E recruitment. J Cell Biol 2015; 209:221–34;
PMID:25918224; http://dx.doi.org/10.1083/jcb.201501090
7. Scrivens PJ, Noueihed B, Shahrzad N, Hul S, Brunet S, Sacher M. C4orf41
and TTC-15 are mammalian TRAPP components with a role at an early
stage in ER-to-Golgi trafficking. Mol Biol Cell 2011; 22:2083–93;
PMID:21525244; http://dx.doi.org/10.1091/mbc.E10-11-0873
8. Wan X, O’Quinn RP, Pierce HL, Joglekar AP, Gall WE, DeLuca JG,
Carroll CW, Liu ST, Yen TJ, McEwen BF, et al. Protein architecture of
the human kinetochore microtubule attachment site. Cell 2009;
137:672–84;
PMID:19450515;
http://dx.doi.org/10.1016/j.
cell.2009.03.035
9. Royle SJ. Mitotic moonlighting functions for membrane trafficking proteins. Traffic 2011; 12; 791–8; PMID:21564450; http://dx.doi.org/
10.1111/j.1600-0854.2011.01184.x